Disclosures for "Intravenous Thrombolysis Versus Conservative Therapy in Extracranial Artery Dissection-related Ischemic Stroke: A Double-arm Meta-analysis of Functional and Safety Outcomes"
-
Dr. Thapa has nothing to disclose.
-
Dr. Shah has nothing to disclose.
-
Dr. Elmashad has nothing to disclose.
-
Dr. Medicherla has nothing to disclose.
-
Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .